EISSN 2475-0581

IMPACT FACTOR: 0.5 INDEXED IN WEB OF SCIENCE

Psychiatry and Clinical Psychopharmacology

34 138 2024

HIGHLY CITED ARTICLES

The Effect of COVID-19 Pandemic on Psychosomatic Complaints and Investigation of The Mediating Role of Intolerance to Uncertainty, Biological Rhythm Changes and Perceived COVID-19 Threat in this Relationship: A Web-Based Community Survey

by Gıca et al.

COVID-19 Vaccine Hesitancy and Its Relationship With Illness Risk Perceptions, Affect, Worry, and Public Trust: An Online Serial Cross-Sectional Survey From Turkey

by Kucukkarapinar et al.

Evaluation of the Psychiatric Research Output From Turkey Via Web of Science Database: A Bibliometric Analysis

by Topal et al.

High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study

by Fernandez- Miranda et al.

Video/Computer Game Addiction Among University Students in Ghana: Prevalence, Correlates and Effects of Some Demographic Factors

by Miezah et al.

Burnout, Job Satisfaction, and Psychological Symptoms Among Emergency Physicians During COVID-19 Outbreak: A Cross-Sectional Study

by Bahadırlı and Sağaltıcı.

Parental Attachment and the Theory of Mind Abilities as Predictors of Internet Addiction in Turkish Adolescents

by Akdeniz et al.

Investigating the Impact of the ECT on Thiol-Disulphide Homeostasis in Depressive Disorders

by Atagün et al.

Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists

by Aydin et al.

Adaptation of Internet Gaming Cognition Scale to Turkish: Reliability and Validity Study

by Cakiroglu and Soylu.

Original Papers

Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey

Ozgur Oner ¹ , Hakan Turkcapar ² , Fatma Isli ³ , Hasan Karadag ⁴ , Akif Akbulat ³ , Ali Boray Basci ³ , Mesil Aksoy ³ , Cem Seckin ³ , Ali Alkan ³

Author Affiliation(s)

1.

Ankara University, School of Medicine, Department of Child and Adolescent Psychiatry, Ankara - Turkey

2.

Hasan Kalyoncu University, Department of Psychology, Istanbul - Turkey

3.

Ministry of Health, Ankara - Turkey

4.

Diskapi Yildirim Bayazit Hospital, Deparment of Psychiatry, Ankara - Turkey Corresponding

Psychiatry and Clinical Psychopharmacology 2016; 26: 265-272

DOI: 10.5455/bcp.20151202103706

Keywords : ADHD, treatment, OROS, methylphenidate, atomoxetine

Read: 2320 Downloads: 653 Published: 21 January 2021

Volume 26, Issue 3, September 2016

Previous Article

Objective: To determine the factors associated with type of ADHD prescription and re-admission of the cases to the outpatient clinics between January-July 2013.

Method: The Ministry of Health prescription database, which included prescriber, region, age and gender data and contained almost 20% of IMS data.

Results: A total of 73,189 prescription were prescribed to a total of 41,341 (30,014 males; 72.7%) patients. 38645 (93.5%) of the patients were between 6 and 18 years of age. The most frequently prescribed drug was OROS methylphenidate (MPH, 59.7%) followed by IR MPH, atomoxetine and combination of drugs. There were several regional differences in prescription practice. Treatment choice changed significantly with age and gender. Rate of repeated prescription was highest among 6-18 year-old male subjects receiving combination treatment.

Conclusions: ADHD treatment choice seemed to be heavily influenced by official regulations. Age, gender and drug of choice were important factors associated with treatment adherence.

Files